Aerius International, Inc. (AERS) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAerius International, Inc. (AERS) trades at $0.0042. Aerius International, Inc. provides consulting, design, construction, and financing services to marijuana operators in the United States. The company is based in Las Vegas, Nevada, and operates within the industrial sector. Sector: Industrials.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for AERS: AERS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AERS against Industrials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
AERS: the 2 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Aerius International, Inc. (AERS) Industrial Operations Profile
Aerius International, Inc. offers specialized consulting, design, construction, and financing solutions tailored for marijuana operators in the U.S. market. Based in Las Vegas, the company distinguishes itself through its focus on this niche sector within the broader industrial landscape, providing end-to-end services for cannabis businesses.
What Is the Investment Thesis for AERS?
Aerius International, Inc. presents a focused investment opportunity within the niche market of providing services to marijuana operators. The company's specialized expertise in consulting, design, construction, and financing caters directly to the needs of businesses in this rapidly growing industry. Key value drivers include the expansion of legalized marijuana markets across the U.S. and the increasing demand for professional services to navigate regulatory complexities. Potential catalysts include new state-level legalization initiatives and strategic partnerships with established cannabis companies. However, investors should be aware of risks such as evolving regulations, competition from larger consulting firms, and the company's current market capitalization of $0.00B.
Based on FMP financials and quantitative analysis
AERS Key Highlights
Aerius International, Inc. focuses on providing consulting, design, construction, and financing services, creating a diversified revenue stream within the cannabis industry.
- The company's location in Las Vegas, Nevada, provides access to a growing cannabis market and a hub for industry innovation.
- Aerius International, Inc. operates in the consulting services industry, which is expected to grow as more states legalize marijuana and businesses seek professional guidance.
- The company's negative P/E ratio of -18.22 indicates it is currently not profitable, requiring careful monitoring of its financial performance.
- The beta of -0.20 suggests the stock is less volatile than the market, but this may also reflect its limited trading activity and market capitalization.
Who Are AERS's Competitors?
AERS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EPOW Sunrise New Energy Co., Ltd. | $0.33 | -7.50% | $9.56M | 479-signal |
| GRNQ Greenpro Capital Corp. | $11.76 | -11.11% | $21.3M | — |
| AERT Aeries Technology, Inc. | $6.78 | +1.04% | $38.9M | 825-pillar |
| RYOJ rYojbaba Co., Ltd. | $4.75 | +1.06% | $54.9M | 565-pillar |
| RGP Resources Connection, Inc. | $3.89 | +0.52% | $134M | 345-pillar |
| FORR Forrester Research, Inc. | $11.84 | -1.66% | $230M | 555-pillar |
| SBC SBC Medical Group Holdings Incorporated | $4.44 | +0.91% | $457M | 925-pillar |
| ROMA Roma Green Finance Limited | $9.44 | +5.14% | $562M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are AERS's Key Strengths?
Specialized expertise in the marijuana industry.
- Comprehensive service offerings.
- Established relationships with marijuana operators.
- Focus on a niche market.
What Are AERS's Weaknesses?
Small market capitalization.
- Limited financial resources.
- Dependence on the marijuana industry.
- Negative P/E ratio.
What Could Drive AERS Stock Higher?
Potential legalization of marijuana in additional states, expanding the market for Aerius International's services.
- Increasing demand for professional consulting and design services in the cannabis industry.
- Strategic partnerships with established cannabis companies to expand market reach.
What Are the Key Risks for AERS?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Evolving regulations in the marijuana industry could impact Aerius International's business model.
- Competition from larger consulting firms with greater resources.
- Dependence on the marijuana industry, which is subject to regulatory and market fluctuations.
- The company's small market capitalization and limited financial resources may constrain its growth potential.
What Are the Growth Opportunities for AERS?
- Expansion into New Markets: As more states legalize marijuana, Aerius International has the opportunity to expand its services into these new markets. Each new state represents a potential source of revenue and growth. The timeline for this growth is dependent on the pace of legalization efforts across the U.S., but represents a significant long-term opportunity.
- Strategic Partnerships: Forming strategic partnerships with established cannabis companies can provide Aerius International with access to a broader client base and increased project opportunities. These partnerships can also enhance the company's credibility and market presence. The timeline for securing these partnerships is ongoing, with potential deals emerging as the industry matures.
- Development of New Service Offerings: Aerius International can expand its service offerings to include specialized areas such as regulatory compliance, security solutions, and technology integration. This diversification can attract a wider range of clients and increase revenue per client. The timeline for developing these new services is estimated at 12-18 months per service.
- Focus on Sustainable Practices: As environmental concerns grow, Aerius International can differentiate itself by offering consulting services focused on sustainable and environmentally friendly practices for marijuana cultivation and processing. This can attract clients who prioritize sustainability and enhance the company's brand image. The timeline for implementing this strategy is ongoing.
- Leveraging Technology: Integrating technology solutions, such as data analytics and project management software, can improve the efficiency and effectiveness of Aerius International's services. This can lead to cost savings, improved client satisfaction, and a competitive advantage. The timeline for implementing these technologies is estimated at 6-12 months.
What Threats Does AERS Face?
- Evolving regulations in the marijuana industry.
- Competition from larger consulting firms.
- Changes in public opinion towards marijuana.
- Economic downturn affecting the cannabis industry.
What Are AERS's Competitive Advantages?
- Specialized expertise in the marijuana industry.
- Comprehensive service offerings covering consulting, design, construction, and financing.
- Established relationships with marijuana operators.
- Focus on a niche market with high barriers to entry.
What Does AERS Do?
Aerius International, Inc., headquartered in Las Vegas, Nevada, specializes in providing comprehensive consulting, design, construction, and financing services exclusively for marijuana operators within the United States. The company was founded to address the unique challenges and opportunities present in the burgeoning cannabis industry, offering a suite of services designed to support businesses from initial concept through to operational success. Aerius International assists clients with navigating the complex regulatory landscape, designing efficient and compliant facilities, overseeing construction projects, and securing necessary financing. The company's focus on the marijuana industry allows it to develop specialized expertise and tailored solutions that meet the specific needs of its clients. Aerius aims to be a one-stop-shop for marijuana businesses seeking to establish or expand their operations.
What Products and Services Does AERS Offer?
- Provides consulting services to marijuana operators.
- Offers design services for cannabis facilities.
- Manages construction projects for marijuana businesses.
- Arranges financing for cannabis-related ventures.
- Assists clients with navigating regulatory requirements.
- Supports businesses in the marijuana industry from concept to operation.
How Does AERS Make Money?
- Generates revenue through consulting fees.
- Earns income from design and construction project management.
- Receives commissions or fees for arranging financing.
- Focuses on serving marijuana operators in the United States.
What Industry Does AERS Operate In?
Aerius International operates within the consulting services industry, specifically catering to the marijuana sector. This industry is experiencing rapid growth due to the increasing legalization of marijuana across the United States. The competitive landscape includes both specialized firms like Aerius and larger consulting companies that offer services to the cannabis industry as part of a broader portfolio. Aerius differentiates itself through its exclusive focus on marijuana operators, allowing it to develop deep expertise and tailored solutions.
Who Are AERS's Key Customers?
- Marijuana cultivators.
- Cannabis processors.
- Dispensary owners.
- Investors in the marijuana industry.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 44 |
| 2026-08-26 | 44 |
| 2026-08-29 | 44 |
| 2026-09-01 | 44 |
| 2026-09-04 | 44 |
| 2026-09-07 | 44 |
| 2026-09-10 | 44 |
What changed?
The score has stayed at 44.
Over the same 18 days the stock moved +121.1%.
Financial Health
Aerius International, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Quarterly Financial Performance: Aerius International, Inc.
Revenue for Aerius International, Inc. came in at $0 during Q2 FY2026. The company recorded a net loss of $27K, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Industrials. Across the four most recent quarters, AERS averaged $-0.00 in diluted EPS.
Key Financial Metrics
Return on equity for Aerius International, Inc. stands at 42.1%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -4.5%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Aerius International, Inc. operates in the Consulting Services industry within the Industrials sector. It is headquartered in Las Vegas, US. The company is led by CEO Sean Parvizian. AERS has traded publicly since 2010.
AERS Financials
Bull Case vs Bear Case
Bull Case
- Specialized expertise in the marijuana industry.
- Comprehensive service offerings.
- Established relationships with marijuana operators.
- Focus on a niche market.
Bear Case
- Small market capitalization.
- Limited financial resources.
- Dependence on the marijuana industry.
- Negative P/E ratio.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $0 | -$27,003 | -$0.0001 |
| Q1 FY2026 | $0 | -$31,300 | -$0.0001 |
| Q4 FY2025 | $0 | -$213,623 | -$0.0010 |
| Q3 FY2025 | $0 | -$11,032 | -$0.0000 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
AERS Latest News
No recent news available for AERS.
AERS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AERS.
Price Targets
Wall Street price target analysis for AERS.
AERS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AERS; grades run from A+ (80-100) to F (below 30).
Leadership: Robert Jerhoff
CEO title
Robert Jerhoff serves as the CEO of Aerius International, Inc. Further research would be needed to provide a comprehensive overview of his career history, education, and previous roles.
Track Record: Due to the limited information available, it is not possible to assess Robert Jerhoff's track record at Aerius International, Inc. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown.
AERS OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Aerius International, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited financial disclosure, and may not be subject to the same level of regulatory oversight. This tier is generally associated with higher risk and greater potential for volatility compared to companies listed on national exchanges due to less stringent listing requirements.
- OTC Tier: OTC Other
- Limited financial disclosure due to lower reporting requirements.
- Higher potential for fraud or manipulation due to less regulatory oversight.
- Greater price volatility due to lower trading volume and liquidity.
- Increased risk of delisting or going out of business.
- Difficulty in obtaining accurate and reliable information about the company.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the company's capital structure and potential dilution.
- Monitor trading volume and price volatility.
- Consult with a financial advisor or legal professional.
- Existence of a physical address and contact information.
- Presence of a professional website with detailed information about the company.
- Availability of some financial information, even if limited.
- Positive news coverage or industry recognition.
- Active engagement with investors and stakeholders.
What Investors Ask About Aerius International, Inc. (AERS) — Industrials
Is AERS a good stock?
Stock Expert AI does not rate AERS buy, sell or hold. Aerius International, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What do analysts say about AERS stock?
There is currently no available analyst coverage for Aerius International, Inc. This lack of coverage is likely due to the company's small market capitalization and its listing on the OTC Other tier.
What are the key factors to evaluate for AERS?
Evaluate AERS on fundamentals, analyst consensus, and risk factors. Each new state represents a potential source of revenue and growth. Not financial advice.
How frequently does AERS data refresh on this page?
AERS's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven AERS's recent stock price performance?
Aerius International, Inc. (AERS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in the marijuana industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AERS overvalued or undervalued right now?
Aerius International, Inc. (AERS) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of AERS?
Yes, most major brokerages offer fractional shares of Aerius International, Inc. (AERS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track AERS's earnings and financial reports?
Aerius International, Inc. (AERS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for AERS earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Aerius International, Inc.
- OTC Other tier carries higher risks.